Posted: November 16, 2011 – A recent study showed that breast cancer survivors who underwent chemotherapy have reduced activity in areas of the prefrontal cortex that supports working memory, cognitive control, monitoring, and executive function. The study reflects other findings that show impaired attention and memory in cancer survivors who have had chemotherapy.
Cogmed stands as a possible intervention for this population. There are several ongoing studies examining the efficacy of Cogmed on survivors of various forms of cancer to improve working memory and cognitive function.
You can see an interview with a cancer survivor who went through the Cogmed program by clicking here.